FREQUENCY OF SPREAD OF BRONCHIAL ASTHMA AMONG MIDDLE-AGED PEOPLE AND EFFECTIVENESS OF TREATMENT. Almaty, City Clinical Hospital No. 1

Kuralsynova Marzhan; Bakytova Aidana; Omarova Kh.S.

doi:10.31435/rsglobal_ws/30012022/7747

FREQUENCY OF SPREAD OF BRONCHIAL ASTHMA AMONG MIDDLE-AGED PEOPLE AND EFFECTIVENESS OF TREATMENT. Almaty, City Clinical Hospital No. 1

Kuralsynova Marzhan Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Bakytova Aidana Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Omarova Kh.S. аssistant at the Department of General Medical Practice №1 of Asfendiyarov Kazakh National Medical University

DOI: https://doi.org/10.31435/rsglobal_ws/30012022/7747

Keywords: bronchial asthma, risk factors, triggers, tartrazine, treatment

Abstract

Bronchial asthma (BA) is a global problem. The incidence of bronchial asthma is growing all over the world. It is among the top ten noncommunicable chronic diseases, which are the main cause of death among people, reducing life expectancy by 6.6 years for men and 13.5 years for women.

References

И. Воржева «Аспириновая бронхиальная астма: особенности диагностики и лечения». Практическая пульмонология №1, 2015.

Визель А.А., Гильманов А.А., Самерханова А. Е., Гизатуллина Е. Д., Буниатин А.А. «Сравнение острого бронхиолитического эффекта ингаляционных растворов Беродуал и Салгим с использованием небулайзера у больных хроническим обструктивным бронхитом и бронхиальной астмой».

Views:

216

Downloads:

167

Published

2022-01-10

Citations

How to Cite

Kuralsynova Marzhan, Bakytova Aidana, & Omarova Kh.S. (2022). FREQUENCY OF SPREAD OF BRONCHIAL ASTHMA AMONG MIDDLE-AGED PEOPLE AND EFFECTIVENESS OF TREATMENT. Almaty, City Clinical Hospital No. 1. World Science, (1(73). https://doi.org/10.31435/rsglobal_ws/30012022/7747

Download Citation

Issue

No 1(73) (2022): World Science

Section

Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.

All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.